IQVIA Holdings Inc. (NYSE:IQV) Receives $255.82 Consensus Target Price from Analysts

IQVIA Holdings Inc. (NYSE:IQV) has received a consensus recommendation of “Moderate Buy” from the twenty-one analysts that are currently covering the stock, MarketBeat reports. Three research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating on the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $255.82.

A number of equities research analysts recently issued reports on IQV shares. Leerink Partners reissued an “outperform” rating and set a $248.00 price target (down from $260.00) on shares of IQVIA in a research note on Tuesday, November 19th. StockNews.com lowered shares of IQVIA from a “buy” rating to a “hold” rating in a research note on Thursday, November 28th. Bank of America reduced their price target on shares of IQVIA from $255.00 to $235.00 and set a “buy” rating on the stock in a research note on Friday, December 13th. The Goldman Sachs Group lowered their price objective on shares of IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Finally, Morgan Stanley reduced their target price on shares of IQVIA from $280.00 to $265.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Capital Performance Advisors LLP acquired a new position in shares of IQVIA during the third quarter valued at about $27,000. Park Place Capital Corp purchased a new position in shares of IQVIA in the third quarter worth $28,000. Itau Unibanco Holding S.A. acquired a new stake in shares of IQVIA during the second quarter worth $29,000. International Assets Investment Management LLC purchased a new stake in shares of IQVIA during the second quarter valued at $32,000. Finally, Avior Wealth Management LLC raised its stake in IQVIA by 117.6% in the 3rd quarter. Avior Wealth Management LLC now owns 161 shares of the medical research company’s stock worth $38,000 after acquiring an additional 87 shares during the last quarter. 89.62% of the stock is owned by institutional investors and hedge funds.

IQVIA Stock Up 1.7 %

NYSE IQV opened at $202.63 on Wednesday. The firm has a market capitalization of $36.78 billion, a price-to-earnings ratio of 26.59, a PEG ratio of 2.05 and a beta of 1.48. IQVIA has a 52 week low of $187.62 and a 52 week high of $261.73. The company has a fifty day moving average of $202.22 and a two-hundred day moving average of $221.94. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 1.76.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.